BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary
disease that frequently leads to end-stage renal disease and is a common indication for …

Kidney transplantation is indicated for end-stage renal disease. Autosomal dominant
polycystic kidney disease (ADPKD) causes structural degeneration of the kidney and …

INTRODUCTION: Kidneys from donors affected by autosomal-dominant polycystic kidney
disease (ADPKD) are in general considered unsuitable for transplantation. To the best of our …

Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of end-stage
renal disease and a common indication for renal transplantation. Patients with ADPKD show …

Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following
renal transplantation. Background Posttransplant diabetes mellitus is an important …

Background. Autosomal dominant polycystic kidney disease (ADPKD) is the most common
genetic disorder leading to end‐stage renal failure. The objective of this study was to …

Transplantation is the optimal choice for renal replacement therapy in patients with
autosomal dominant polycystic kidney disease (ADPKD). However, some specific issues …

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder affecting 1
in 1,000 people and responsible for 10% of cases of the end stage renal disease (ESRD) …

Renal transplantation in patients with autosomal dominant polycystic kidney disease
(ADPKD) is a medical and surgical challenge. Detailed longitudinal epidemiological studies …

Background and objectives: For patients with end-stage renal disease (ESRD), the best
replacement therapy is renal transplant (RTx) to ensure life with good quality. Autosomal …